HBSAG LOSS WITH TENOFOVIR DISOPROXIL FUMARATE PLUS PEGINTERFERON ALFA-2A IN CHRONIC HEPATITIS B: LONG-TERM RESULTS OF A GLOBAL RANDOMIZED CONTROLLED TRIAL
dc.contributor.author | Elkhashab, M. | |
dc.contributor.author | Ahn, S. -H. | |
dc.contributor.author | Marcellin, P. | |
dc.contributor.author | Ma, X. | |
dc.contributor.author | Caruntu, F. | |
dc.contributor.author | Tak, W. Y. | |
dc.contributor.author | Chuang, W. -L. | |
dc.contributor.author | Mehta, R. | |
dc.contributor.author | Petersen, J. | |
dc.contributor.author | Corsa, A. | |
dc.contributor.author | Martins, E. B. | |
dc.contributor.author | Yee, L. J. | |
dc.contributor.author | Dinh, P. | |
dc.contributor.author | Subramanian, G. Mani | |
dc.contributor.author | Buti, M. | |
dc.contributor.author | Gaeta, G. | |
dc.contributor.author | Papatheodoridis, G. | |
dc.contributor.author | Flisiak, R. | |
dc.contributor.author | Chan, H. L. Y. | |
dc.contributor.author | Tabak, F. | |
dc.date.accessioned | 2021-03-03T10:54:01Z | |
dc.date.available | 2021-03-03T10:54:01Z | |
dc.identifier.citation | Ahn S. -. , Marcellin P., Ma X., Caruntu F., Tak W. Y. , Elkhashab M., Chuang W. -. , Tabak F., Mehta R., Petersen J., et al., "HBSAG LOSS WITH TENOFOVIR DISOPROXIL FUMARATE PLUS PEGINTERFERON ALFA-2A IN CHRONIC HEPATITIS B: LONG-TERM RESULTS OF A GLOBAL RANDOMIZED CONTROLLED TRIAL", EASL International Liver Congress, Barcelona, İspanya, 13 - 17 Nisan 2016, cilt.64 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_2531a849-f94f-4751-9bae-ba865d7b68aa | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/29894 | |
dc.identifier.uri | https://doi.org/10.1016/s0168-8278(16)00924-7 | |
dc.language.iso | eng | |
dc.subject | Gastroenteroloji-(Hepatoloji) | |
dc.subject | GASTROENTEROLOJİ VE HEPATOLOJİ | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.title | HBSAG LOSS WITH TENOFOVIR DISOPROXIL FUMARATE PLUS PEGINTERFERON ALFA-2A IN CHRONIC HEPATITIS B: LONG-TERM RESULTS OF A GLOBAL RANDOMIZED CONTROLLED TRIAL | |
dc.type | Bildiri | |
dc.contributor.department | Yonsei University , , | |
dc.identifier.volume | 64 | |
dc.contributor.firstauthorID | 148643 |
Bu öğenin dosyaları:
Dosyalar | Boyut | Biçim | Göster |
---|---|---|---|
Bu öğe ile ilişkili dosya yok. |
Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.
-
Bildiri [64839]